| |

Radiotherapy ‘Comparable to Chemo’ for Mesothelioma

15102946_radiation

A recent study has concluded that palliative radiotherapy produces a response rate in malignant pleural mesothelioma that is comparable to chemotherapy.

A recent analysis of 54 mesothelioma cases at a hospital in Cheltenham, England found that 43 percent of patients who received palliative radiotherapy according to their hospital’s policy, responded to the treatment. Based on the results of their pre- and post-therapy CT scans, 22 of the 54 mesothelioma patients analyzed experienced a partial response and 1 patient had a complete response. Fifty-seven percent reported some improvement in their symptoms.

In an effort to help determine which mesothelioma patients are most likely to respond to radiotherapy, the research team correlated treatment responses with the European Organisation for Research and Treatment of Cancer (EORTC) prognostic index. Among the patients judged to be in the ‘good’ prognosis group, 56 percent responded to the radiotherapy, compared to just 7 percent of patients in the ‘poor’ prognosis group. The EORTC good and poor prognostic mesothelioma groups had survival of 7.1 and 2.1 months respectively from the start of their treatment.

In addition to the EORTC index, survival following radiotherapy treatment was also correlated with each patient’s mesothelioma histological subtype, performance status, treatment response and hemoglobin level. Neither tumor volume nor the stage of the patients’ cancer was associated with prognosis. The study concluded that palliative radiotherapy for mesothelioma “produces a response rate that is equivalent to chemotherapy” and recommends the EORTC prognostic index as a method of deciding which patients may benefit from this treatment most.

Although the English study was focused solely on the role of radiotherapy, a number of previous studies have found radiotherapy to be most effective when used as part of a multimodality approach to mesothelioma treatment. One such study from the National Cancer Institute in Cairo found that more than 75 percent of patients who had radiation as part of their treatment protocol saw a response (either a decrease in the size of their tumors or in the severity of their symptoms). Recurrence rates were lowest in patients who had high dose hemithorax (one side of the chest) irradiation, a method typically reserved for the healthiest mesothelioma patients.

Sources:

Jenkins, P et al, “Re-evaluation the role of palliative radiotherapy in malignant pleural mesothelioma”, June 7, 2011, European Journal of Cancer, Epub ahead of print. El Hossieny, Hesham et al, “Analysis of the Effect of Radiotherapy on Malignant Pleural Mesothelioma when Given on Adjuvant or Palliate Basis”, January 1, 2010.

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…